Weight-Loss Drug Developer Metsera Reveals Wider Loss in US IPO Filing
Metsera, founded in 2022 by venture capital firm ARCH Venture and investment firm Population Health Partners, revealed a net ...
Metro Times16h
What Is the Ideal Semaglutide Dose for Weight Loss?
The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...
Understanding pros and cons of medical weight loss drugs: What you need to know
As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...
"They're not shortcuts": How weight loss drugs became the business of shame
The use of GLP-1 drugs sparked the term "Ozempic shaming" to describe the negative perceptions faced by those who choose ...
Missouri IndeMissouri Independentpendent7h
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
ITU22h
Facts and Figures 2022
These are just some of the insights that can be found in the 2022 edition of Facts and Figures, ITU’s annual global assessment of digital connectivity. It features estimates for key connectivity ...